Masimo Corp. v. Mallinckrodt Inc.

18 F. App'x 852
Court of Appeals for the Federal Circuit·Decided August 8, 2001·No. No. 01-1038·Published·Cited by 3 cases

Opinions

DECISION

LOURIE, Circuit Judge.

Masimo Corporation appeals from the decision of the United States District Court for the Central District of California granting Mallinckrodt Inc. and Nellcor Puritan Bennett, Inc.’s (collectively, “the defendants’ ”) motion for summary judgment of noninfringement of U.S. Patent 6,036,-642 and denying Masimo’s motion for a preliminary injunction. Masimo Corp. v. Mallinckrodt Inc., No. SA-CV-99-1245 (C.D.Cal. Oct. 6, 2000). Because the district court did not err, we affirm.

DISCUSSION

Masimo is the assignee of the ’642 patent, which relates to a pulse oximeter that removes undesired noise from signals containing information pertaining to a patient’s arterial blood oxygen saturation level. A typical input signal received by a pulse oximeter is comprised of a plethys-mographic wave portion, which contains the desired saturation information, and an undesired noise portion, which is usually caused by patient movement during the measurement process. ’642 patent, col. 1, II. 63-67. In the present invention, both red and infrared light are simultaneously shone through a patient’s body tissue, thus creating two such input signals at different wavelengths having correlated noise portions. Id. at col. 9, II. 49-53. The claimed pulse oximeter receives these input signals and generates a noise reference signal using known absorption coefficients of the patient’s body tissue and the correlated noise data from the input signals. Id. at col. 16, I. 19 to col. 18, I. 21. Finally, an adaptive noise canceler is employed to remove all frequencies that are common to the noise reference signal and one of the input signals, leaving only the oxygen saturation information from the plethysmo-graphic wave portion of that input signal. Id. at col. 18, II. 65-67.

Claims 16 and 28 of the ’642 patent are at issue, and only one limitation present in both claims is relevant to this appeal. Claim 16 reads as follows:

1. A pulse oximeter which measures the oxygen saturation of blood in body tissue, said pulse oximeter comprising:
a light emitter adapted to emit light of at least first and second wavelengths;
a light detector responsive to light from said light emitter which has passed through body tissue having blood, said light detector providing intensity signals;
an adaptive filter responsive to said intensity signals to provide at least one filtered signal; and
an oxygen saturation module responsive to at least said filtered signal to calculate oxygen saturation of said blood.

Id. at col. 42, II. 17-29 (emphasis added). Claim 28 is similar to claim 16, except that claim 28 uses the term “adaptive signal processor” instead of “adaptive filter.”

Free access — add to your briefcase to read the full text and ask questions with AI

Masimo Corp. v. Mallinckrodt Inc., 18 F. App'x 852 (Fed. Cir. 2001).

18 F. App'x 852 (Masimo Corp. v. Mallinckrodt Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Acacia Media Technologies Corp. v. New Destiny Internet Group
405 F. Supp. 2d 1127 (N.D. California, 2005)
Mallinckrodt, Inc. v. Masimo Corp.
147 F. App'x 158 (Federal Circuit, 2005)
Mallinckrodt, Inc. v. Masimo Corp.
254 F. Supp. 2d 1140 (C.D. California, 2003)